
Wee Koon Heng - Educated at the National University of Singapore (BBA), Nanjing University (MBA) and a Chartered Financial Analyst (CFA), Wee Koon was a Deal Advisory Partner with KPMG Singapore. He was the Senior Advisor to a Japanese boutique M&A firm listed on Tokyo Stock Exchange and assisted in its overseas expansion into Singapore, Malaysia and Thailand before starting his own firm. He is also currently on the board of Hyphens Pharma listed on Singapore Stock Exchange as the Lead Independent Director and Audit Committee Chairman.
Wee Koon Heng joined CBA as M&A Advisor in Singapore in March 2025.
This website uses cookies to enhance your experience. Some are essential for site functionality, while others help us analyze and improve your usage experience. Please review your options and make your choice.
If you are under 16 years old, please ensure that you have received consent from your parent or guardian for any non-essential cookies.
Your privacy is important to us. You can adjust your cookie settings at any time. For more information about how we use data, please read our privacy policy. You may change your preferences at any time by clicking on the settings button below.
Note that if you choose to disable some types of cookies, it may impact your experience of the site and the services we are able to offer.
Some required resources have been blocked, which can affect third-party services and may cause the site to not function properly.
This website uses cookies to enhance your browsing experience and ensure the site functions properly. By continuing to use this site, you acknowledge and accept our use of cookies.
![cba logo1[1]](https://cba.associates/wp-content/uploads/2026/02/cba-logo11.jpg)

![companies wanted1[1]](https://cba.associates/wp-content/uploads/2026/02/companies-wanted11.png)
![FastMatch logo with Buyer Finder transparent new 11[1]](https://cba.associates/wp-content/uploads/2026/02/FastMatch-logo-with-Buyer-Finder-transparent-new_111.png)